[ivory-search id="184" title="Recordati AJAX Search Form"]

Terms of Use

All content of this internet site is owned or controlled by Recordati Rare Diseases Inc. (“RRD”).  The RecordatiRareDiseases.com/us website (together with the websites of all related entities, the “Site”) is an interactive online service operated by RRD.  PLEASE READ THESE TERMS OF USE CAREFULLY BEFORE USING THE SITE. By using the Site, you signify your agreement to these Terms of Use and RRD’s Privacy Policy. If you do not agree to these Terms of Use, please do not use the Site. Please check these Terms of Use periodically for changes. Your continued use of the Site will mean you accept these changes. RRD reserves the right to modify, suspend, terminate, or restrict your use of any portion of the Site at any time, without notice.


  1. Introduction This website provides information available about a range of topics. Like any printed material, it may become out of date over time. It is important that consumers rely on the advice of a healthcare professional to employ good clinical judgment for the specific conditions of individual patients. This information is not intended to be a substitute for the advice of a healthcare professional, or a recommendation for any particular treatment plan.

    All medical, pharmaceutical and other product information contained on the Site is provided by RRD and is intended solely for residents of the U.S.   A product identified on this website may be available only by prescription through your local healthcare provider. RRD is not engaged in rendering medical advice or services, and no diagnosis or prescription should be concluded or inferred by information provided on this website. Nothing contained on the Site should be construed as a solicitation or promotion for any product or service or for the use of any product in a particular way which is not authorized by the laws and regulations of the country where the reader is located.

    Certain sections of the Site may have separate registration procedures and separate terms and conditions, terms of service, user agreements or similar legal agreement that may be offered by RRD or its third party service providers. When you are using any section of the Site that does not have a separate legal agreement or terms of use, these Terms of Use shall apply.

  2. Restrictions on Use of Materials Except as otherwise authorized in writing by RRD, all materials contained on the Site are the copyrighted property of RRD and/or third party licensors. No material from this website may be copied, reproduced, republished, uploaded, posted, transmitted, or distributed in any way, except that you may download the materials for your personal, non-commercial home use only, provided that you keep intact all copyright and other proprietary notices, you make no modifications to the materials, and you do not use the materials in a manner that suggests an association with any of our products, services, or brands. The use of any material contained on the Site in any non personal or commercial manner is prohibited, unless you have obtained prior written approval from RRD. Nothing contained herein shall be construed as conferring by implication, estoppel, or otherwise any license or right under any patent, trademark, copyright or other intellectual property right of RRD or any third party.

    All trademarks and service marks identified by ®, (TM) or (SM) symbols or appearing in type form different from that of the surrounding text are marks owned by or licensed to RRD or third parties.

  3. Children 

    The Site is not intended for use by persons under the age of 18. By submitting information to the Sites, you have indicated that you are at least 18 years old or older.

  4. General Submissions 

    Except as otherwise provided in the Privacy Policy, any suggestions, comments, questions, information or the like submitted to RRD shall be deemed to be non-confidential and RRD shall have no obligation of any kind with respect to such information. By making a submission to RRD, you assign to RRD all rights, title and interest in and to such submission, and RRD shall be free to use, display, distribute, copy and otherwise use the submission for any purpose, without limitation, the research, development, manufacture, use or sale of products incorporating information contained in such submission. Please see RRD’s Privacy Policy for more information about RRD’s collection, use and disclosure practices with respect to information collected from you on the Site.

  5. Third Party Information and Links 

    The Site may contain third party information or content. Such information or content is, wherever practically possible, marked with the name of the source and does not necessarily represent the opinion or viewpoint of RRD. RRD does not take any responsibility whatsoever for such third party information or content. As a convenience to you, this website may provide links to third party websites. RRD has no responsibility for, or control of, the content appearing on third party sites and shall not be liable for any damages or injury arising from the content of those sites. Further, RRD disclaims any responsibility for the accuracy, content, or availability of information found on sites that link to or from the Site from third parties not associated with us.

  6. Limitation of Liability 

    YOUR SOLE AND EXCLUSIVE REMEDY FOR ANY OTHER DISPUTE WITH US IS TO DISCONTINUE YOUR USE OF THE SITE. TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, IN NO EVENT SHALL RECORDATI RARE DISEASES, INC., ITS LICENSORS, ITS SUPPLIERS, OR ANY THIRD PARTIES MENTIONED ON THE SITE BE LIABLE FOR ANY DAMAGES (INCLUDING, WITHOUT LIMITATION, INCIDENTAL, SPECIAL, INDIRECT AND CONSEQUENTIAL DAMAGES, PERSONAL INJURY/WRONGFUL DEATH, LOST PROFITS, OR DAMAGES RESULTING FROM LOST DATA OR BUSINESS INTERRUPTION) RESULTING FROM THE USE OR INABILITY TO USE THE SITE, RELIANCE UPON ANY STATEMENT OR INFORMATION OR CONTENT PROVIDED BY THE SITE, OR ANY FAILURE OF PERFORMANCE, ERROR, OMISSION, INTERRUPTION, EFFECT, DELAY IN OPERATION OR TRANSMISSION, COMPUTER VIRUS, LINE SYSTEM FAILURE, LOSS OF DATA, OR LOSS OF USE RELATED TO THE SITE OR ANY SITE OPERATED BY ANY THIRD PARTY, WHETHER BASED ON WARRANTY, CONTRACT, TORT, OR ANY OTHER LEGAL THEORY, AND WHETHER OR NOT RRD IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. IF YOU ARE DISSATISFIED WITH US, ANY OF OUR SERVICES OR THESE TERMS OF USE, YOUR SOLE AND EXCLUSIVE REMEDY IS TO DISCONTINUE USE OF THE SITE.


Last Updated: January 1, 2020
See also our Privacy Policy

© 2024 Recordati Rare Diseases Inc.
NP-RRD-US-0136

You are about to leave this site and visit the recordati global website?

To continue please click the link below.

Visit Global Site

You are about to leave this site and visit the recordati global website?

To continue please click the link below.

Visit Global Site

You are about to leave this site and visit the recordati global website?

To continue please click the link below.

Visit Global Site
Recordati for the planet
A clean environment is essential for people’s well-being: the health of the planet and the health of people is tightly interconnected. Environmental elements, such as air, water, land and climate, all have an impact on the well-being of humans. Placing a focus on people’s health and being sustainable therefore also means prioritising environmental protection and a responsibility towards future generations. This is why the Group ensures that it conducts business in a socially responsible manner and in accordance with sustainable practices, national and international laws, and the expectations of stakeholders.
Recordati for the community
We believe that contributing to the well-being of the community and dedicating part of our resources to acts of solidarity is not merely the fulfilment of company obligations or professional duty, but rather a moral imperative, an essential part of a healthy business capable of growth but at the same time able to support and develop the community in which it operates and make its employees proud.
Value and diversity of our people
At Recordati, we believe in equal opportunities and we guarantee that everyone can achieve their potential. We see diversity as a value and will not tolerate any discrimination based on ethnicity, nationality, gender, sexual orientation, disability, age, political or religious belief, or any other personal characteristics. At Recordati, we work hard to create a safe and inclusive work environment, where we all have our rights to physical and psychological integrity respected on a daily basis, as well as our right to freedom of opinion and association. We recognise that we each have a role to play in the success of our business and we implement staff development policies through which everyone’s contribution and achievements can be appropriately rewarded.
Multiple opportunities
Recordati is uniquely structured to bring treatment options across specialty and primary care, consumer healthcare, and rare diseases. We have fully integrated operations across research and development, chemical and finished product manufacturing through to commercialisation and licensing.
Luigi Longinotti
Managing Director and General Manager EMEA

Luigi Longinotti is Managing Director and General Manager for EMEA at Recordati Rare Diseases, leading the European and Middle Eastern Commercial Operations. He is responsible for Marketing, Medical, Market Access, Regulatory, Manufacturing and Logistics, as well as the enabling functions to support the business, including Compliance and Quality.

 

He joined Recordati in July 2014 as Corporate Portfolio Management Director for Orphan Drugs. In such a role he has been responsible for driving the growth of the rare disease portfolio at Recordati, with his duties ranging from business development to strategic marketing and pipeline project management.

 

Before he joined Recordati, he held senior business and corporate development roles at Chiesi Farmaceutici and Menarini Group where he executed several key asset deals and transactions.

Luigi gained a degree in Economics from the University of Florence and a Master’s degree in Business Innovation from Sant’Anna School of Advanced Studies in Pisa.

Bruno Parenti
Head of LAC Region, Head of Global Endocrinology Franchise

Bruno Parenti is Head of LAC Region at Recordati Rare Diseases, leading the business in Latin America, Asia Pacific and Russia. He has been in this position since 2011, where he spearheaded the expansion of operations around the globe. He recently assumed the additional role of Head of Global Endocrinology Franchise, establishing the new HQ in Basel and building a dedicated organization.

 

Prior to these positions, Bruno spent two years at Recordati Ireland overseeing international sales in the Asia-Pacific region. He served at Chiesi Farmaceutici for two years as Area Manager for the Far East. Earlier in his career, he held commercial roles at Kedrion Biopharmaceuticals where he was responsible for international markets with a focus on Latin America and the Middle East.

Scott Pescatore
Executive Vice President

Scott Pescatore is Vice President and Head of Global Operations at Recordati Rare Diseases.

He holds a Doctor of Pharmacy degree and completed his post-doctoral fellowship in Pharmacology and Drug Development. Dr Pescatore has spent over 20 years working internationally in the pharmaceutical industry, specializing in oncology, haematology and rare diseases.

 

He joined Novartis Oncology US in 2001 where he served in various medical, sales and marketing roles of increasing responsibility. In 2008, he moved to Novartis Oncology UK as Business Franchise Head for solid tumours where he also managed the New Products portfolio. In 2010 he moved to Milan to manage the Region Europe Haematology Franchise where he led the joint venture between Novartis Oncology and Incyte to launch a novel treatment for myeloproliferative disorders. In 2014 he was appointed the Oncology General Manager in Ireland and after three years returned to Milan as General Manager of the Region Europe Rare Disease Business Unit, overseeing operations in 37 markets and focusing on the endocrinology portfolio.

 

Prior to joining Recordati Rare Diseases in 2020, he was Vice President Oncology Business Unit for AstraZeneca Italy where he was responsible for the portfolio of oncology/haematology products including two joint ventures with MSD and Daiichi Sankyo.

You are about to leave this site and visit the recordati global website?

To continue please click the link below.

Visit Global Site